EMHTF - Emerald Health Therapeutics GAAP EPS of -C$0.02 revenue of C$3.04M July, 11 2022 07:59 AM Emerald Health Therapeutics Emerald Health Therapeutics press release ( OTCQX:EMHTF ): Q1 GAAP EPS of -C$0.02. Revenue of C$3.04M (+14.7% Y/Y) Cash and cash equivalents of C$16.15M For further details see: Emerald Health Therapeutics GAAP EPS of -C$0.02, revenue of C$3.04M